Observational Study to Evaluate the Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2018
Price : $35 *
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors EHL Bio
- 12 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Feb 2018 Status changed from active, no longer recruiting to recruiting.
- 30 Jan 2018 Status changed from recruiting to active, no longer recruiting.